-
1
-
-
0028557296
-
Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: An open trial
-
Kafka MP. Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiatry 1994;6:189-195
-
(1994)
Ann Clin Psychiatry
, vol.6
, pp. 189-195
-
-
Kafka, M.P.1
-
2
-
-
0026754517
-
Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men
-
Kafka MP, Prentky R. Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiatry 1992;53:351-358
-
(1992)
J Clin Psychiatry
, vol.53
, pp. 351-358
-
-
Kafka, M.P.1
Prentky, R.2
-
3
-
-
84870465485
-
-
American Psychiatric Association, Fourth Edition. Washington, DC: American Psychiatric Association;
-
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
-
(1994)
Diagnostic and Statistical Manual of Mental Disorders
-
-
-
4
-
-
0033985595
-
The epidemiology and phenomenology of compulsive sexual behavior
-
Black DW. The epidemiology and phenomenology of compulsive sexual behavior. CNS Spectrums 2000;5:26-35
-
(2000)
CNS Spectrums
, vol.5
, pp. 26-35
-
-
Black, D.W.1
-
5
-
-
0033979097
-
Psychopharmacological treatments for nonparaphitic compulsive sexual behaviors
-
Kafka MP. Psychopharmacological treatments for nonparaphitic compulsive sexual behaviors. CNS Spectrums 2000;5:49-59
-
(2000)
CNS Spectrums
, vol.5
, pp. 49-59
-
-
Kafka, M.P.1
-
6
-
-
85039143894
-
-
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2004. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/ reports/2004report/rA/2004SurveillanceReport.pdf. Accessibility verified September 26, 2006
-
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2004. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/ reports/2004report/rA/2004SurveillanceReport.pdf. Accessibility verified September 26, 2006
-
-
-
-
7
-
-
0030758586
-
HIV-seropositive men who engage in high-risk sexual behavior: Psychological characteristics and implications for prevention
-
Kalichman SC, Greenberg J, Abel GG. HIV-seropositive men who engage in high-risk sexual behavior: psychological characteristics and implications for prevention. AIDS Care 1997;9:441-450
-
(1997)
AIDS Care
, vol.9
, pp. 441-450
-
-
Kalichman, S.C.1
Greenberg, J.2
Abel, G.G.3
-
8
-
-
0030457686
-
A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: A retrospective study
-
Greenberg DM, Bradford JM, Curry S, et al. A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: a retrospective study. Bull Am Acad Psychiatry Law 1996;24:525-532
-
(1996)
Bull Am Acad Psychiatry Law
, vol.24
, pp. 525-532
-
-
Greenberg, D.M.1
Bradford, J.M.2
Curry, S.3
-
9
-
-
0033854007
-
Sexual side effects of antidepressants
-
Rothschild AJ. Sexual side effects of antidepressants. J Clin Psychiatry 2000;61(suppl 11):28-36
-
(2000)
J Clin Psychiatry
, vol.61
, Issue.SUPPL. 11
, pp. 28-36
-
-
Rothschild, A.J.1
-
10
-
-
0001661458
-
The World Health Organization Composite International Diagnostic Interview Short Form (CIDI-SF)
-
Kessler RC, Andrews G, Mroczek D, et al. The World Health Organization Composite International Diagnostic Interview Short Form (CIDI-SF). Int J Methods Psychiatr Res 1998;7:171-185
-
(1998)
Int J Methods Psychiatr Res
, vol.7
, pp. 171-185
-
-
Kessler, R.C.1
Andrews, G.2
Mroczek, D.3
-
11
-
-
85039141936
-
-
First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition SCID-I/P, Version 2.0, New York, NY: Biometrics Research, New York State Psychiatric Institute; 1995
-
First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1995
-
-
-
-
12
-
-
0008946321
-
ECDEU Assessment Manual for Psychopharmacology
-
Rockville, Md: National Institute of Mental Health;
-
Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:217-222
-
(1976)
US Dept Health, Education, and Welfare publication (ADM) 76-338
, pp. 217-222
-
-
Guy, W.1
-
13
-
-
0000058049
-
An application of an URN model to the design of sequential controlled clinical trials
-
Wei LJ. An application of an URN model to the design of sequential controlled clinical trials. J Am Statist Assoc 1978;73:559-563
-
(1978)
J Am Statist Assoc
, vol.73
, pp. 559-563
-
-
Wei, L.J.1
-
14
-
-
0029549281
-
Clinical implications of antidepressant drug effects on sexual function
-
Harvey KV, Balon R. Clinical implications of antidepressant drug effects on sexual function. Ann Clin Psychiatry 1995;7:189-201
-
(1995)
Ann Clin Psychiatry
, vol.7
, pp. 189-201
-
-
Harvey, K.V.1
Balon, R.2
-
15
-
-
0024435153
-
The Yale-Brown Obsessive Compulsive Scale, 1: Development, use, and reliability
-
Goodman WK, Price LH, Rasmussen SA. The Yale-Brown Obsessive Compulsive Scale, 1: development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011
-
(1989)
Arch Gen Psychiatry
, vol.46
, pp. 1006-1011
-
-
Goodman, W.K.1
Price, L.H.2
Rasmussen, S.A.3
-
16
-
-
0034194232
-
A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling
-
Hollander E, De Caria CM, Finkell JN, et al. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol Psychiatry 2000;47:813-817
-
(2000)
Biol Psychiatry
, vol.47
, pp. 813-817
-
-
Hollander, E.1
De Caria, C.M.2
Finkell, J.N.3
-
17
-
-
0030935539
-
A severity rating scale for body dysmorphic disorder: Development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale
-
Phillips KA, Hollander E, Rasmussen SA, et al. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull 1997;33:17-22
-
(1997)
Psychopharmacol Bull
, vol.33
, pp. 17-22
-
-
Phillips, K.A.1
Hollander, E.2
Rasmussen, S.A.3
-
18
-
-
0026546333
-
Obsessive and compulsive characteristics of alcohol abuse and dependence: Quantification by a newly developed questionnaire
-
Modell JG, Glaser FB, Mountz JM, et al. Obsessive and compulsive characteristics of alcohol abuse and dependence: quantification by a newly developed questionnaire. Alcohol Clin Exp Res 1992;16:266-271
-
(1992)
Alcohol Clin Exp Res
, vol.16
, pp. 266-271
-
-
Modell, J.G.1
Glaser, F.B.2
Mountz, J.M.3
-
19
-
-
0034948389
-
Compulsive Sexual Behavior Inventory: A preliminary study of reliability and validity
-
Coleman E, Miner M, Ohlerking F, et al. Compulsive Sexual Behavior Inventory: a preliminary study of reliability and validity. J Sex Marital Ther 2001;27:325-332
-
(2001)
J Sex Marital Ther
, vol.27
, pp. 325-332
-
-
Coleman, E.1
Miner, M.2
Ohlerking, F.3
-
20
-
-
0031670688
-
Reliability of the Timeline Follow-Back sexual behavior interview
-
Weinhardt LS, Carey MP, Maisto SA, et al. Reliability of the Timeline Follow-Back sexual behavior interview. Ann Behav Med 1998;20:25-30
-
(1998)
Ann Behav Med
, vol.20
, pp. 25-30
-
-
Weinhardt, L.S.1
Carey, M.P.2
Maisto, S.A.3
-
22
-
-
0033979236
-
The Arizona Sexual Experience Scale (ASEX): Reliability and validity
-
McGahuey CA, Gelenberg AJ, Laukes CA, et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000;26:25-40
-
(2000)
J Sex Marital Ther
, vol.26
, pp. 25-40
-
-
McGahuey, C.A.1
Gelenberg, A.J.2
Laukes, C.A.3
-
23
-
-
0042844766
-
Divalproex in the treatment of impulsive aggression: Efficacy in cluster B personality disorders
-
Hollander E, Tracy KA, Swann AC, et al. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology 2003;28:1186-1197
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 1186-1197
-
-
Hollander, E.1
Tracy, K.A.2
Swann, A.C.3
-
24
-
-
0023020183
-
The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations
-
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-1182
-
(1986)
J Pers Soc Psychol
, vol.51
, pp. 1173-1182
-
-
Baron, R.M.1
Kenny, D.A.2
-
25
-
-
12444303223
-
The Internet and family and acquaintance sexual abuse
-
Mitchell KJ, Finkelhor D, Wolak J. The Internet and family and acquaintance sexual abuse. Child Maltreat 2005;10:49-60
-
(2005)
Child Maltreat
, vol.10
, pp. 49-60
-
-
Mitchell, K.J.1
Finkelhor, D.2
Wolak, J.3
-
26
-
-
0033803289
-
Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: A case series
-
Kafka MP, Hennen J. Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: a case series. J Clin Psychiatry 2000;61:664-670
-
(2000)
J Clin Psychiatry
, vol.61
, pp. 664-670
-
-
Kafka, M.P.1
Hennen, J.2
-
27
-
-
0027198922
-
Biological approaches to treatment-resistant obsessive-compulsive disorder
-
Goodman WK, McDougle CJ, Barr LC, et al. Biological approaches to treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 1993;54(6, suppl):16-26
-
(1993)
J Clin Psychiatry
, vol.54
, Issue.6 and SUPPL.
, pp. 16-26
-
-
Goodman, W.K.1
McDougle, C.J.2
Barr, L.C.3
-
28
-
-
0042130101
-
A review of pharmacologic treatments for obsessive-compulsive disorder
-
Kaplan A, Hollander E. A review of pharmacologic treatments for obsessive-compulsive disorder. Psychiatr Serv 2003;54:1111-1118
-
(2003)
Psychiatr Serv
, vol.54
, pp. 1111-1118
-
-
Kaplan, A.1
Hollander, E.2
-
29
-
-
27744566213
-
Is there a placebo problem in antidepressant trials?
-
Yang H, Cusin C, Fava M. Is there a placebo problem in antidepressant trials? Curr Top Med Chem 2005;5:1077-1086
-
(2005)
Curr Top Med Chem
, vol.5
, pp. 1077-1086
-
-
Yang, H.1
Cusin, C.2
Fava, M.3
|